Barclays
MXCT icon

Barclays’s MaxCyte MXCT Stock Holding History

Barclays’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Sell
163,062
-137,218
-46% -$128K ﹤0.01% 3972
2025
Q4 		$465K Buy
300,280
+8,639
+3% +$13.8K ﹤0.01% 3894
2025
Q3 		$461K Sell
291,641
-29,590
-9% -$51.4K ﹤0.01% 3861
2025
Q2 		$700K Buy
321,231
+206,459
+180% +$500K ﹤0.01% 3565
2025
Q1 		$313K Sell
114,772
-49,260
-30% -$194K ﹤0.01% 3810
2024
Q4 		$682K Sell
164,032
-1,733
-1% -$6.55K ﹤0.01% 3636
2024
Q3 		$645K Buy
165,765
+127,156
+329% +$536K ﹤0.01% 3620
2024
Q2 		$151K Sell
38,609
-40,623
-51% -$175K ﹤0.01% 3720
2024
Q1 		$332K Sell
79,232
-58,599
-43% -$275K ﹤0.01% 3837
2023
Q4 		$648K Buy
137,831
+106,266
+337% +$414K ﹤0.01% 3717
2023
Q3 		$98.5K Sell
31,565
-3,359
-10% -$13.5K ﹤0.01% 3606
2023
Q2 		$160K Sell
34,924
-42,954
-55% -$197K ﹤0.01% 3354
2023
Q1 		$385K Buy
77,878
+47,281
+155% +$233K ﹤0.01% 3442
2022
Q4 		$167K Buy
30,597
+19,377
+173% +$119K ﹤0.01% 3949
2022
Q3 		$72K Sell
11,220
-1,572
-12% -$8.77K ﹤0.01% 3660
2022
Q2 		$61K Sell
12,792
-20,437
-62% -$101K ﹤0.01% 3963
2022
Q1 		$233K Buy
33,229
+32,039
+2,692% +$219K ﹤0.01% 3329
2021
Q4 		$12K Sell
1,190
-29
-2% -$311 ﹤0.01% 3985
2021
Q3 		$15K Buy
+1,219
New +$18.4K ﹤0.01% 4452

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Barclays's MXCT Position: Q1 2026 in Review

Barclays reduced its MaxCyte (MXCT) stake by 46% in Q1 2026, selling an estimated $128K and leaving 163,062 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #3972.

Barclays first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $700K in Q2 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Barclays held 163,062 shares of MaxCyte worth $115K as of Q1 2026.
  • Barclays sold 137,218 MaxCyte shares in Q1 2026, an estimated $128K.
  • MaxCyte made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3972 holding.
  • Barclays first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Barclays's MaxCyte position peaked at $700K in Q2 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.